Biological systems rarely fail all at once—cells signal the earliest signs of drift, stress, or potency loss long before traditional assays detect a problem. LumaCyte’s combined machine learning and multivariate analytics framework transforms these subtle, force‑dependent cellular‑response signatures into clear, early indicators that help teams optimize processes, strengthen control strategies, and prevent downstream failures. By identifying these shifts earlier and with greater precision, teams can build more consistent, scalable processes that support advanced regulatory strategies and ultimately accelerate commercial readiness and patient access.
Unlike conventional machine learning approaches that rely on broad, multi‑input datasets and largely retrospective patterns, LumaCyte’s platform is built on real‑time, label‑free measurements captured at the single‑cell level. By grounding machine learning in the actual biochemical and biophysical behavior of individual cells, developers gain a far more precise and biologically truthful view of cellular dynamics—one that predicts functional outcomes rather than inferring them from markers or bulk averages.
Powered by Laser Force Cytology™ and the Radiance® instrument, this capability gives teams a new level of visibility into how cells behave—and how this behavior can impact downstream outcomes.

